Heike Launhardt

Title: Heike Launhardt - Innovator in Glycosylation Technologies

Introduction

Heike Launhardt, an accomplished inventor based in Freiburg, Germany, has made significant strides in the field of biotechnology. With a focus on producing glycosylated proteins, Launhardt is recognized for his innovative methods that leverage non-animal eukaryotic cells.

Latest Patents

Launhardt holds a patent for his invention titled "Transformed plant cell expressing five mammalian proteins involved in sialylation and a protein involved in galactosylation." This invention relates to a method for producing heterologous glycosylated proteins in non-animal eukaryotic cells, including transformed bryophyte, yeast, ciliate, or algae cells. The method aims to produce glycosylated proteins that carry animal glycosylation patterns, which are essential for pharmaceuticals intended for use in mammals, including humans. It encompasses the genetic materials necessary for this production, including DNA and RNA, and highlights the novel polypeptides and proteins that can be obtained through this innovative method. Additionally, the invention includes a method for producing sialic acid or CMP-sialic acid in these transformed non-mammalian eukaryotic cells.

Career Highlights

Heike Launhardt is currently associated with Greenovation Biotech GmbH, where he applies his expertise to advance biotechnology. His innovative contributions are vital in the exploration of new methodologies for the production of therapeutic proteins.

Collaborations

Throughout his career, Launhardt has collaborated with talented professionals, including Gilbert Gorr and Marta Rodriguez Franco. These partnerships enhance his research capabilities and facilitate knowledge exchange within the field.

Conclusion

Heike Launhardt's contributions to biotechnology through his patent on glycosylated protein production are significant. His work at Greenovation Biotech GmbH, combined with effective collaborations, positions him as a key figure in advancing innovations in this important sector. The potential applications of his inventions could lead to substantial improvements in pharmaceutical development for mammalian use.